APA

AlAsmari A. F., Ali N., AlAsmari F., AlAnazi W. A., AlShammari M. A., Al-Harbi N. O., Alhoshani A., As Sobeai H. M., AlSwayyed M., AlAnazi M. M. & AlGhamdi N. S. (2020). Liraglutide attenuates gefitinib-induced cardiotoxicity and promotes cardioprotection through the regulation of MAPK/NF-κB signaling pathways. : Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

Chicago

AlAsmari Abdullah F, Ali Nemat, AlAsmari Fawaz, AlAnazi Wael A, AlShammari Musaad A, Al-Harbi Naif O, Alhoshani Ali, As Sobeai Homood M, AlSwayyed Mohammed, AlAnazi Mohammed M and AlGhamdi Nader S. 2020. Liraglutide attenuates gefitinib-induced cardiotoxicity and promotes cardioprotection through the regulation of MAPK/NF-κB signaling pathways. : Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

Harvard

AlAsmari A. F., Ali N., AlAsmari F., AlAnazi W. A., AlShammari M. A., Al-Harbi N. O., Alhoshani A., As Sobeai H. M., AlSwayyed M., AlAnazi M. M. and AlGhamdi N. S. (2020). Liraglutide attenuates gefitinib-induced cardiotoxicity and promotes cardioprotection through the regulation of MAPK/NF-κB signaling pathways. : Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

MLA

AlAsmari Abdullah F, Ali Nemat, AlAsmari Fawaz, AlAnazi Wael A, AlShammari Musaad A, Al-Harbi Naif O, Alhoshani Ali, As Sobeai Homood M, AlSwayyed Mohammed, AlAnazi Mohammed M and AlGhamdi Nader S. Liraglutide attenuates gefitinib-induced cardiotoxicity and promotes cardioprotection through the regulation of MAPK/NF-κB signaling pathways. : Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society. 2020.